resiquimod has been researched along with naphthoquinones in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (naphthoquinones) | Trials (naphthoquinones) | Recent Studies (post-2010) (naphthoquinones) |
---|---|---|---|---|---|
465 | 14 | 318 | 7,110 | 149 | 2,923 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di, T; Li, P; Lin, Y; Liu, X; Meng, Y; Ruan, Z; Wang, M; Wang, N; Wang, Y; Xie, X; Zhang, L; Zhao, J | 1 |
1 other study(ies) available for resiquimod and naphthoquinones
Article | Year |
---|---|
Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway.
Topics: Animals; Cell Differentiation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Imidazoles; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-23; Lithospermum; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Naphthoquinones; Psoriasis; Skin; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2016 |